Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation

Hematology Journal

Volumn 5, Issue SUPPL. 3, 2004, Pages

  Velardi, Andrea ^a   Ruggeri, Loredana ^a   Capanni, Marusca ^a   Mancusi, Antonella ^a   Perruccio, Katia ^a   Aversa, Franco ^a   Martelli, Massimo Fabrizio ^a  

^a Div of Hematol/Clin Immunology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ALLELE; ALLOIMMUNITY; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; DISEASE SEVERITY; GENOTYPE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HAPLOIDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HLA TYPING; HUMAN; IMMUNOTHERAPY; NATURAL KILLER CELL; NONHUMAN;

EID: 4043147135     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200429     Document Type: Article

References (20)

1. Anasetti C, Velardi A. Haematopoietic cell transplantation from hla partially matched related donors. In: Blume KG, Forman SJ, Appelbaum FR (eds). Haematopoietic Cell Transplantation, 3rd edn. Blackwell Science: Oxford, 2004.
2. Reisner Y, Martelli MF. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunol Today 1995; 16: 437-440.
3. Reisner Y, Kapoor N, Kirkpatrick D, Pollack MS, Cunningham-Rundles S, Dupont B et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutimin and sheep red blood cells. Blood 1983; 61: 341-348.
4. Bachar-Lustig E, Rachamim N, Li HW, Lan F, Reisner Y. Megadose of T-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1995; 1: 1268-1273.
5. Aversa F, Tabilio A, Terenzi A, Velardi A, Falzetti F, Giannoni C et al. Successful engraftment of T-depleted haploidentical 'three-loci' incompatible transplants in leukaemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948-3955.
6. Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F et al. Treatment of high risk acute leukaemia with T-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339: 1186-1193.
7. Käre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defence strategy. Nature ?? 319: 675-678.
8. Ciccone E, Pende D, Viale O, Di Donato C, Tripodi G, Orengo AM et al. Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans. J Exp Med 1992; 175: 709-718.
9. Ciccone E, Pende D, Viale O, Than A, Di Donato C, Orengo AM et al. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med 1992; 176: 963-971.
10. Colonna M, Brooks EG, Falco M, Ferrara GB, Strominger JL. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 1993; 260: 1121-1124.
11. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci USA 1993; 90: 1200-1204.
12. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997; 7: 753-760.
13. Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA. Natural Killer cell receptors: new biology and insights into the graft versus leukaemia effect. Blood 2002; 100: 1935-1947.
14. Velardi A, Ruggeri L, Moretta A, Moretta L. NK-cells: a lesson from mismatched haematopoietic transplantation. Trends Immunol 2002; 23: 438-444.
15. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A et al. Effectiveness of donor natural killer cell alloreactivity in mismatched haematopoietic transplants. Science 2002; 295: 2097-2100.
16. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999; 285: 412-415.
17. Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, Perruccio K et al. Role of natural killer cell alloreactivity in HLA-mismatched haematopoietic stem cell transplantation. Blood 1999; 94: 333-339.
18. Käre K. A perfect mismatch. Science 2002; 295: 2029-2031.
19. Parham P, McQueen KL. Alloreactive killer cells: hindrance and help for haematopoietic transplants. Nat Rev Immunol 2003; 3: 108-122.
20. Pando MJ, Gardiner CM, Gleimer M, McQueen KL, Parham P. The protein made from a common allele of KIR3DL1 (3DL*004) is poorly expressed at cell surfaces due to substitution at position 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol 2003; 171: 6640-6647.